Episode Details

Quantexa, a British AI powerhouse poised for a potential billion-dollar IPO, is weighing U.S. or UK listings—or both—as it eyes a major stock market debut. Ready since January, the company’s decision remains fluid, with staying private still on the table. With a £175 million fraud-fighting contract from Britain’s revenue agency and a shot at an NHS patient record project, Quantexa’s tech helps clients tame big data while keeping control. Meanwhile, Warburg Pincus—holding 9-10%—is quietly exploring a stake sale, though no deal is confirmed. As London battles to lure tech firms home, Quantexa’s path underscores the global tug-of-war over where innovation goes public.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/8fec24b5e4e087a4